Close

Gilead Sciences (GILD) Misses Q3 EPS by 11c; Reiterates Outlook

Go back to Gilead Sciences (GILD) Misses Q3 EPS by 11c; Reiterates Outlook

UPDATE: BMO Capital Maintains Gilead Sciences (GILD) at Market Perform (Correction)

November 2, 2016 6:56 AM EDT

(Updated - November 2, 2016 7:17 AM EDT)

(Gilead was not upgraded to Outperform, remains Market Perform at BMO.)

BMO Capital maintained its Market Perform rating on Gilead Sciences (NASDAQ: GILD) with a price target of $84 (prior $98). Comments follow Q3 results.... More

Gilead Sciences (GILD) Declares $0.47 Quarterly Dividend; 2.5% Yield

November 1, 2016 4:04 PM EDT

Gilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.47 per share, or $1.88 annualized.

The dividend will be payable on December 29, 2016, to stockholders of record on December 15, 2016, with an ex-dividend date of December 13, 2016.

The annual yield on the dividend is 2.5... More